Matthew Collins, MD, PhD
Biography
Dr. Matthew Collins, Associate Professor of Medicine, Division of Infectious Diseases, Emory University
Background
Dr. Collins trained in Internal Medicine at Boston Medical Center and completed an Infectious Diseases fellowship at the University of North Carolina at Chapel Hill. He completed a combined MD/PhD program at the Medical College of Georgia and University of Georgia, studying T cell responses to the protozoan parasite Trypanosoma cruzi for his doctorate work. During his fellowship, he joined a dengue research group just before the Zika epidemic was announced in Brazil in 2015. He learned the basics of arbovirology but also what it's like to be “in the field” during the emergence of a previously obscure pathogen. He currently leads a laboratory research program investigating adaptive immunity to tropical and emerging viruses and provides consulting services in ambulatory Travel Medicine and inpatient Infectious Diseases. Dr. Collins is a member of the Hope Clinic team, which is the clinical arm of the Emory Vaccine Center, where he contributes to clinical trials assessing several vaccines and other intervention strategies for preventing infectious diseases.
Professional Highlights
- Adjunct Clinical Research Instructor, Division of Infectious Diseases Department of Medicine, University of North Carolina School of Medicine 2017-present
- Expert Working Group (Emerging Infections), 2020-present, Infectious Diseases Clinical Research Consortium (IDCRC) Leadership Group DMID, NIAID, NIH
- Expert Working Group (Monkeypox), 2022-present, Infectious Diseases Clinical Research Consortium (IDCRC) Leadership Group, Division of Microbiology and Infectious Diseases, NIAID, NIH
- Infectious Diseases Research Seminar Organizing Committee, 2019-present
- 2022 Emory School of Medicine Researcher Appreciation Day Recognition
Areas of Interest
- Understanding human antibody responses elicited by viral infections and vaccination.
- Applying serologic tools to address immunologic or epidemiological questions.
- Defining clinical trial endpoints
- Pathogens: Dengue, Zika and Yellow Fever